References
- Nakashima T, Sato H, Gyo K, et al. Idiopathic sudden sensorineural hearing loss in Japan. Acta Otolaryngol. 2014;134:1158–1163.
- Fetterman BL, Saunders JE, Luxford WM. Prognosis and treatment of sudden sensorineural hearing loss. Am J Otol. 1996;17:529–536.
- Suckfüll M, Wimmer C, Reichel O, et al. Hyperfibrinogenemia as a risk factor for sudden hearing loss. Otol Neurotol. 2002;23:309–311.
- Norris CH. Drugs affecting the inner ear: a review of their clinical efficacy, mechanisms of action, toxicity, and place in therapy. Drugs. 1988;36:754–772.
- McCall AA, Swan EE, Borenstein JT, et al. Drug delivery for treatment of inner ear disease: current state of knowledge. Ear Hear. 2010;31:156–165.
- Wei BP, Mubiru S, O’Leary S. Steroids for idiopathic sudden sensorineural hearing loss. Cochrane Database Syst Rev. 2006;CD003998.
- Conlin AE, Parnes LS. Treatment of sudden sensorineural hearing loss: I. A systematic review. Arch Otolaryngol Head Neck Surg. 2007;133:573–581.
- Conlin AE, Parnes LS. Treatment of sudden sensorineural hearing loss: II. A meta-analysis. Arch Otolaryngol Head Neck Surg. 2007;133:582–586.
- Nakashima T, Kuno K, Yanagita N. Evaluation of prostaglandin E1 therapy for sudden deafness. Laryngoscope. 1989;99:542–546.
- Ogawa K, Takei S, Inoue Y, et al. Effect of prostaglandin E1 on idiopathic sudden sensorineural hearing loss: a double-blinded clinical study. Otol Neurotol. 2002;23:665–668.
- Lee HY, Kim JC, Choi MS, et al. Therapeutic effect of combined steroid-lipoprostaglandin E1 for sudden hearing loss: a propensity score-matched analysis. Am J Otolaryngol. 2015;36:52–56.
- Agarwal L, Pothier DD. Vasodilators and vasoactive substances for idiopathic sudden sensorineural hearing loss. Cochrane Database Syst Rev. 2009;CD003422.
- Wilson WR, Byl FM, Laird N. The efficacy of steroids in the treatment of idiopathic sudden hearing loss. A double-blind clinical study. Arch Otolaryngol. 1980;106:772–776.
- Mattox DE, Simmons FB. Natural history of sudden sensorineural hearing loss. Ann Otol Rhinol Laryngol. 1977;86:463–480.
- Labus J, Stützer H, Michel O. Meta-analysis for the effect of medical therapy vs. placebo on recovery of idiopathic sudden hearing loss. Laryngoscope. 2010;120:1863–1871.
- Stachler RJ, Chandrasekhar SS, Archer SM, et al. Clinical practice guideline: sudden hearing loss. Otolaryngol Head Neck Surg. 2012;146:S1–S35.
- Lee HY, Kim DK, Park YH, et al. Prognostic factors for profound sudden idiopathic sensorineural hearing loss: a multicenter retrospective study. Eur Arch Otorhinolaryngol. 2017;274:143–149.
- Karetova D, Bultas J, Vondracek V, et al. Alprostadil: modes of actions in peripheral arterial occlusive disease. Am J Ther. 1997;4:359–363.
- Ahn JH, Kim TY, Kim YJ, et al. Lipo-prostaglandin E1 in combination with steroid therapy is effective for treatment of sudden sensorineural hearing loss in Korean patients with Type 2 diabetes. Diabet Med. 2006;23:1339–1343.
- Kanzaki J, Inoue Y, Ogawa K, et al. Effect of single-drug treatment on idiopathic sudden sensorineural hearing loss. Auris Nasus Larynx. 2003;30:123–127.